These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 35464718)

  • 1. Recent Advances in Stimuli-Sensitive Amphiphilic Polymer-Paclitaxel Prodrugs.
    Zhou M; Wen L; Wang C; Lei Q; Li Y; Yi X
    Front Bioeng Biotechnol; 2022; 10():875034. PubMed ID: 35464718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-Delivery of Paclitaxel and Doxorubicin by pH-Responsive Prodrug Micelles for Cancer Therapy.
    Jiang Y; Zhou Y; Zhang CY; Fang T
    Int J Nanomedicine; 2020; 15():3319-3331. PubMed ID: 32494132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-assembly of oxidation-responsive polyethylene glycol-paclitaxel prodrug for cancer chemotherapy.
    Dong C; Zhou Q; Xiang J; Liu F; Zhou Z; Shen Y
    J Control Release; 2020 May; 321():529-539. PubMed ID: 32109513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Well-Defined Redox-Sensitive Polyethene Glycol-Paclitaxel Prodrug Conjugate for Tumor-Specific Delivery of Paclitaxel Using Octreotide for Tumor Targeting.
    Yin T; Wu Q; Wang L; Yin L; Zhou J; Huo M
    Mol Pharm; 2015 Aug; 12(8):3020-31. PubMed ID: 26086430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acetal-linked PEGylated paclitaxel prodrugs forming free-paclitaxel-loaded pH-responsive micelles with high drug loading capacity and improved drug delivery.
    Huang D; Zhuang Y; Shen H; Yang F; Wang X; Wu D
    Mater Sci Eng C Mater Biol Appl; 2018 Jan; 82():60-68. PubMed ID: 29025675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. pH-sensitive polymeric micelles formed by doxorubicin conjugated prodrugs for co-delivery of doxorubicin and paclitaxel.
    Ma Y; Fan X; Li L
    Carbohydr Polym; 2016 Feb; 137():19-29. PubMed ID: 26686101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photodynamic PEG-coated ROS-sensitive prodrug nanoassemblies for core-shell synergistic chemo-photodynamic therapy.
    Sun B; Chen Y; Yu H; Wang C; Zhang X; Zhao H; Chen Q; He Z; Luo C; Sun J
    Acta Biomater; 2019 Jul; 92():219-228. PubMed ID: 31078764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-Assembled Redox Dual-Responsive Prodrug-Nanosystem Formed by Single Thioether-Bridged Paclitaxel-Fatty Acid Conjugate for Cancer Chemotherapy.
    Luo C; Sun J; Liu D; Sun B; Miao L; Musetti S; Li J; Han X; Du Y; Li L; Huang L; He Z
    Nano Lett; 2016 Sep; 16(9):5401-8. PubMed ID: 27490088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction-responsive amphiphilic polymeric prodrugs of camptothecin-polyphosphoester for cancer chemotherapy.
    Jin H; Sun M; Shi L; Zhu X; Huang W; Yan D
    Biomater Sci; 2018 May; 6(6):1403-1413. PubMed ID: 29595843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatostatin receptor-mediated specific delivery of paclitaxel prodrugs for efficient cancer therapy.
    Huo M; Zhu Q; Wu Q; Yin T; Wang L; Yin L; Zhou J
    J Pharm Sci; 2015 Jun; 104(6):2018-2028. PubMed ID: 25820241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enzyme-Sensitive and Amphiphilic PEGylated Dendrimer-Paclitaxel Prodrug-Based Nanoparticles for Enhanced Stability and Anticancer Efficacy.
    Li N; Cai H; Jiang L; Hu J; Bains A; Hu J; Gong Q; Luo K; Gu Z
    ACS Appl Mater Interfaces; 2017 Mar; 9(8):6865-6877. PubMed ID: 28112512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Well-defined polymer-drug conjugate engineered with redox and pH-sensitive release mechanism for efficient delivery of paclitaxel.
    Lv S; Tang Z; Zhang D; Song W; Li M; Lin J; Liu H; Chen X
    J Control Release; 2014 Nov; 194():220-7. PubMed ID: 25220162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactive Oxygen Species-Responsive Nanococktail With Self-Amplificated Drug Release for Efficient Co-Delivery of Paclitaxel/Cucurbitacin B and Synergistic Treatment of Gastric Cancer.
    Pang L; Zhang L; Zhou H; Cao L; Shao Y; Li T
    Front Chem; 2022; 10():844426. PubMed ID: 35308794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-Delivery of Paclitaxel by a Capsaicin Prodrug Micelle Facilitating for Combination Therapy on Breast Cancer.
    Lan Y; Sun Y; Yang T; Ma X; Cao M; Liu L; Yu S; Cao A; Liu Y
    Mol Pharm; 2019 Aug; 16(8):3430-3440. PubMed ID: 31199661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, Biological Evaluation and Low-Toxic Formulation Development of Glycosylated Paclitaxel Prodrugs.
    Mao Y; Zhang Y; Luo Z; Zhan R; Xu H; Chen W; Huang H
    Molecules; 2018 Dec; 23(12):. PubMed ID: 30563132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zein-Paclitaxel Prodrug Nanoparticles for Redox-Triggered Drug Delivery and Enhanced Therapeutic Efficiency.
    Hou H; Zhang D; Lin J; Zhang Y; Li C; Wang Z; Ren J; Yao M; Wong KH; Wang Y
    J Agric Food Chem; 2018 Nov; 66(44):11812-11822. PubMed ID: 30339011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyaluronic acid-shelled acid-activatable paclitaxel prodrug micelles effectively target and treat CD44-overexpressing human breast tumor xenografts in vivo.
    Zhong Y; Goltsche K; Cheng L; Xie F; Meng F; Deng C; Zhong Z; Haag R
    Biomaterials; 2016 Apr; 84():250-261. PubMed ID: 26851390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Redox-responsive prodrug for improving oral bioavailability of paclitaxel through bile acid transporter-mediated pathway.
    Lu X; Wu H; Liang Y; Zhang Z; Lv H
    Int J Pharm; 2021 May; 600():120496. PubMed ID: 33746013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjudin-loaded redox-sensitive paclitaxel-prodrug micelles for overcoming multidrug resistance with efficient targeted Colon cancer therapy.
    Chen D; Ge S; Zuo L; Wang S; Liu M; Li S
    Drug Deliv; 2020 Dec; 27(1):1094-1105. PubMed ID: 32706289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual Stimuli-Responsive Polymer Prodrugs Quantitatively Loaded by Nanoparticles for Enhanced Cellular Internalization and Triggered Drug Release.
    Huang M; Zhao K; Wang L; Lin S; Li J; Chen J; Zhao C; Ge Z
    ACS Appl Mater Interfaces; 2016 May; 8(18):11226-36. PubMed ID: 27100328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.